Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Alessandro Cozzi-Lepri und 11 weiteren Autor:innen. Beteiligte Einrichtung: CREME Centre, IGH University College London, London, UK. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences, ViiV Healthcare and Merck Sharp and Dohme.
Abstract (Originalsprache)
Objectives
To estimate the incidence of comorbidities in persons with HIV (PWH) with a stable viral load (VL) of ≤50 copies/mL and evaluate the likelihood of treatment switch (TS) according to the new development of dyslipidaemia (DP), kidney disease and a weight change that determined overweight.
Methods
We carried out six case–control studies nested within the Icona Foundation Study cohort with the outcome of TS of the current regimen (due to intolerance/toxicity or simplification) and investigated the incident comorbidities. Conditional logistic regression models were employed.
Results
Overall, the median age of study participants was 45 years (IQR: 36–52), 19% were female, 48% were MSM and 17% were migrants. DP was confirmed to be the most frequent incident comorbidity [138 events; incidence rate (IR) = 28.4%; 95% CI: 22.7%–34%], followed by estimated glomerular filtration rate (eGFR) deterioration and BMI elevation. None of the studied factors was associated with the risk of TS because of simplification. TS because of toxicity was predicted by incident DP [adjusted OR (aOR) = 2.49, 95% CI: 1.19–5.19, P = 0.02] and by a decline in eGFR of >10 mL/min/1.73 m2 (aOR = 1.51, 95% CI: 0.98–2.32, P = 0.06). The association with DP was stronger in participants who were receiving a boosted PI-based regimen at baseline (aOR = 3.38, 95% CI: 1.11–10.30, P = 0.03). Therapy discontinuation because of toxicity/simplification has remained common in PWH with VL of ≤50 copies/mL in recent years.
Conclusions
The onset of DP and a decline in eGFR was associated with discontinuations due to toxicity. Interventions aiming to mitigate the risk of developing lipid abnormalities in PWH are likely to also reduce the number of ART changes, which can potentially affect future drug options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CREME Centre, IGH University College London, London, UK.
- Icona Foundation, Milano, Italy.
- National PhD Programme in One Health approaches to Infectious Diseases and Life Science Research, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
- Clinic of Infectious Diseases, IRCCS Policlinico San Martino Hospital, Genova, Italy.
- Clinic of Infectious Diseases, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
- School of Medicine, University of Milano-Bicocca, Monza, Italy.
ORCID-Profile: Alessandro Tavelli, Lucia Taramasso, Giovanni Guaraldi, Antonio Di Biagio, Antonella Castagna
Förderung
- Gilead Sciences
- ViiV Healthcare and Merck Sharp and Dohme
Zitieren
APA
Cozzi-Lepri, A., Tavelli, A., Taramasso, L., Lapadula, G., Bobbio, N., Piconi, S., Guaraldi, G., Di Biagio, A., Castagna, A., Mazzotta, V., d'Arminio Monforte, A., & Icona Foundation Study group (2025). Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf137
Vancouver
Cozzi-Lepri A, Tavelli A, Taramasso L, Lapadula G, Bobbio N, Piconi S, et al. Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf137
BibTeX
@article{CozziLepri2025,
author = {Cozzi-Lepri, Alessandro and Tavelli, Alessandro and Taramasso, Lucia and Lapadula, Giuseppe and Bobbio, Nicoletta and Piconi, Stefania and Guaraldi, Giovanni and Di Biagio, Antonio and Castagna, Antonella and Mazzotta, Valentina and d'Arminio Monforte, Antonella and Icona Foundation Study group, Icona Foundation Study group},
title = {Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf137}
}
EUVIMED